Meticulous Research®: IVD Quality Control Market to Reach $2.28 Billion by 2031
|
“” ” |
Meticulous
Research® has released its latest publication, projecting the In
Vitro Diagnostics (IVD) quality control market to achieve a valuation of
$2.28 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.3%
from 2024 to 2031.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3447
1.1.1.1 Market
Growth Drivers
The expansion of the IVD quality control
market is primarily fueled by several factors:
- Rising Prevalence of
Chronic Diseases: An increasing number of chronic disease cases
necessitates accurate diagnostic testing, boosting the demand for quality
controls.
- Aging Population: As the global
geriatric population grows, so does the need for reliable diagnostic
procedures.
- Increasing Clinical
Laboratories:
The proliferation of clinical laboratories worldwide demands robust
quality control measures.
- Point-of-Care (POC) and
Rapid Diagnostics: Growing adoption of POC testing and rapid
diagnostic methods enhances the requirement for quality control products.
- Third-Party Quality
Controls:
There is a rising demand for third-party quality controls and
comprehensive quality assessment reports.
However, stringent technical and
regulatory requirements pose challenges to market growth. Despite these
barriers, opportunities abound with the increasing demand for multi-analyte
and multi-instrument controls.
1.1.1.2 Key Market
Players
Leading companies in the IVD quality
control market include:
- Siemens
Healthineers AG (Germany)
- Bio-Rad
Laboratories, Inc. (U.S.)
- Danaher
Corporation (U.S.)
- LGC
Group (U.K.)
- Thermo
Fisher Scientific Inc. (U.S.)
- SERO
AS (Norway)
- Randox
Laboratories Ltd. (U.K.)
- QuidelOrtho
Corporation (U.S.)
- Streck
LLC (U.S.)
- Microbiologics,
Inc. (U.S.)
- Bio-Techne
Corporation (U.S.)
1.1.1.3 Market
Segmentation
The IVD quality control market is
segmented into several categories:
·
By Offering:
- Quality Control Products:
- By Type: Serum/Plasma-based
Controls, Whole Blood-based Controls, Urine-based Controls, Other
Controls.
- By Function: Independent
Controls, Instrument-specific Controls.
- Quality Assessment
Services
- Data Management
Solutions
Request Sample Report Here @ https://www.meticulousresearch.com/request-sample-report/cp_id=3447
·
By Technology:
- Immunoassay/Immunochemistry
- Biochemistry/Clinical
Chemistry
- Molecular
Diagnostics
- Hematology
- Coagulation/Hemostasis
- Microbiology
- Other
Technologies
·
By Application:
- Infectious
Diseases
- Oncology
- Cardiology
- Autoimmune
Disorders
- Neurology
- Other
Applications
·
By End User:
- Hospitals
& Clinics
- Diagnostic
Laboratories
- Academic
Institutes & Research Laboratories
- Other
End Users
·
By Geography:
- North
America
- Europe
- Asia-Pacific
- Rest
of the World
1.1.1.4 Segment
Highlights
- Quality Control Products: Expected to
dominate in 2024, particularly serum/plasma-based controls, due to their
precision in diagnostic testing.
- Immunoassay/Immunochemistry
Technology:
Anticipated to hold the largest market share in 2024, driven by the high
specificity, sensitivity, and cost-effectiveness of immunoassays.
- Infectious Diseases
Application:
Projected to lead the market share in 2024, propelled by the high
prevalence of diseases like HIV and influenza, and the impact of
pandemics such as COVID-19.
- Hospitals & Clinics: Foreseen to be the
largest end user segment in 2024, supported by the high volume of
diagnostic tests and the rising number of hospital admissions.
1.1.1.5 Regional
Insights
The Asia-Pacific region is expected to
register the highest growth rate during the forecast period. Key drivers
include the burgeoning IVD industry, rising healthcare expenditure, and
improvements in healthcare infrastructure.
About
Meticulous Research®
Meticulous Research® was founded in 2010
and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private
limited company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market intelligence in
North America, Europe, Asia-Pacific, Latin America, and the Middle East &
Africa.
The name of our company defines our
services, strengths, and values. Since the inception, we have only thrived to
research, analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research techniques, we
have built strong capabilities in data collection, interpretation, and
analysis of data including qualitative and quantitative research with the
finest team of analysts. We design our meticulously analyzed intelligent and
value-driven syndicate market research reports, custom studies, quick
turnaround research, and consulting solutions to address business challenges
of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment